ACMO vs. Oncoblast Utilizzo e statistiche
Sidney Kimmel Cancer Center – Jefferson Health offers Advanced Certification Program in Molecular Oncology (ACMO), a case based, self-learning, interactive certification course on molecular oncology, in association with ROCHE and BioQuest Solutions. These online modules help equip community Oncologists/Pathologists in the country with the subject matter expertise and methods of genomic/personalized medicine in order enhance their knowledge and skills and bring a desired change their behaviours from protocol based to individualized patient care.
- App Store di Apple
- Gratis
- Istruzione
Classifica degli store
- -
The OncoBlast app, created by the Binaytara Foundation, offers a unique gaming experience for hematology and oncology providers. This app allows medical professionals in hematology and oncology to engage in educational games, enabling them to earn continuing education credits while playing. OncoBlast is available at no cost and provides interactive, real-time feedback to enhance learning experiences for providers.
The Binaytara Foundation is a non-profit organization dedicated to improving healthcare outcomes through advocacy, education, and innovation. Founded with a vision to create a significant impact in the healthcare sector, the foundation focuses on addressing gaps in medical knowledge and practice, especially in the fields of hematology and oncology. Their commitment to education and training extends beyond traditional methods, embracing technology and interactive platforms to reach a broader audience of healthcare professionals. This app, Oncoblast, takes us one step closer towards this commitment.
- App Store di Apple
- Gratis
- Istruzione
Classifica degli store
- -
ACMORanking a confronto con Oncoblast
Confronta la tendenza di classifica ACMO nei ultimi 28 giorni rispetto a Oncoblast
Rank
Nessun dato disponibile
Classifica ACMO vs. Oncoblast per paese a confronto
Confronta la tendenza di classifica ACMO nei ultimi 28 giorni rispetto a Oncoblast
Nessun dato da visualizzare
Fai confronti con qualsiasi sito con la nostra prova gratuita
ACMO VS.
Oncoblast
23icembre d, 2024